Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia
Álvaro Corral Alaejos, Aránzazu Zarzuelo Castañeda, Silvia Jiménez, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 4, pp. 1913-1924
Open Access | Times Cited: 19

Showing 19 citing articles:

Model-informed precision dosing: State of the art and future perspectives
Iris K. Minichmayr, Erwin Dreesen, Marco Centanni, et al.
Advanced Drug Delivery Reviews (2024) Vol. 215, pp. 115421-115421
Open Access | Times Cited: 14
Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK
Hinojal Zazo Gómez, Eduardo Lagarejos, Manuel Prado-Velasco, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Global research on the utilization of population pharmacokinetic model: a bibliometric analysis from 2000 to 2024
Yu‐Cheng Yao, Liyuan Zhang, Dan Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug–Drug Interaction and Improving Clinical Practice
Félicien Le Louedec, Florent Puisset, Étienne Chatelut, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 1, pp. 55-66
Closed Access | Times Cited: 8
Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation
Shiyu He, Qian-hang Shao, Jinxia Zhao, et al.
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 5, pp. 399-410
Closed Access | Times Cited: 5
Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients
Jaya Shree Dilli Batcha, Vikram Gota, Saikumar Matcha, et al.
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 1, pp. 35-44
Open Access | Times Cited: 1
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Bram C. Agema, Tolra Kocher, Ayşenur B Öztürk, et al.
Clinical Pharmacokinetics (2024)
Open Access | Times Cited: 1
Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia
Bharati Shriyan, Parsshava Mehta, Anand Patil, et al.
European Journal of Clinical Pharmacology (2022) Vol. 78, Iss. 8, pp. 1321-1330
Closed Access | Times Cited: 6
Machine Learning Models for Predicting Personalized Tacrolimus Stable Dosages in Pediatric Renal Transplant Patients
Sergio Sánchez-Herrero, Laura Calvet, Ángel A. Juan
BioMedInformatics (2023) Vol. 3, Iss. 4, pp. 926-947
Open Access | Times Cited: 3
Assessing Dose-Exposure–Response Relationships of Miltefosine in Adults and Children using Physiologically-Based Pharmacokinetic Modeling Approach
Shadrack J. Madu, Ke Wang, Siri Kalyan Chirumamilla, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 12, pp. 2983-3000
Open Access | Times Cited: 2
Embedding R inside the PhysPK Bio-simulation Software for Pharmacokinetics Population Analysis
Sergio Sánchez-Herrero, Fernando Martinez, Jenifer Serna, et al.
BIO Integration (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 1
Innovative Pharmacometric Approaches to Inform Drug Development and Clinical Use
Zinnia P. Parra‐Guillén, Víctor Mangas‐Sanjuán, Hugo Geerts, et al.
Frontiers research topics (2024)
Open Access
Application of stochastic simulation-estimation approach to the optimization of Pharmacokinetic studies design in the context of paediatric extrapolation: A step toward better decision making for drug sponsors and regulators
Happy Phanio Djokoto, Lana Ernst, Jean‐Michel Dogné, et al.
Research Square (Research Square) (2024)
Open Access
Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer
Niels Westra, Paul D. Kruithof, Sander Croes, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 4, pp. 517-526
Open Access
Prevalence, associated causes, and explanatory variables of non-adherence of generic imatinib in chronic myeloid leukemia
J.I. Estrada Acevedo, Juliana Madrigal-Cadavid, Alejandra Rendón-Montoya, et al.
Salud UIS (2024) Vol. 56, Iss. 1
Open Access
Generative Artificial Intelligence Models inPharmacokinetics: A Study on aTwo-Compartment Population Model
Sergio Sánchez Herrero, Laura Calvet
Research Square (Research Square) (2024)
Open Access
Anticipating Leucovorin Rescue Therapy in Patients with Osteosarcoma through Methotrexate Population Pharmacokinetic Model
Laura Ben Olivo, Pricilla de Oliveira Henz, Sophia Wermann, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1180-1180
Open Access
External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high‐flux intermittent haemodialysis
Cheng Ji, Jonathan García, Argem Joy Sabuga, et al.
British Journal of Clinical Pharmacology (2024)
Open Access
Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID‐19 patients in New York City
Alex K. Lyashchenko, Yifan Yu, Donald J. McMahon, et al.
British Journal of Clinical Pharmacology (2022) Vol. 89, Iss. 1, pp. 299-315
Open Access | Times Cited: 2
Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors
Jurij Zdovc, Mihaela Vaupotič, Gregor Marolt, et al.
Cancer Chemotherapy and Pharmacology (2022) Vol. 90, Iss. 4, pp. 301-313
Closed Access | Times Cited: 2
Page 1

Scroll to top